Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Colon Peritoneal Metastases - a Multicentre Phase II Randomized Trial (PIPOX02)

NCT06681038 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT06681038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Colon Peritoneal Metastases - a Multicentre Phase II Randomized Trial (PIPOX02)
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
August 31, 2029
Enrollment
114 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal metastases from colorectal cancer